Table 2.
TRV-130-bound MOR
|
morphine-bound MOR
|
||
---|---|---|---|
residue/ligand | contribution | residue/ligand | contribution |
TRV-130 | 0.56 | D1643.49 | 0.75 |
Y1062.42 | 0.44 | F1082.44 | 0.65 |
W133(EC1) | 0.42 | Y1062.42 | 0.56 |
Y1493.34 | 0.4 | I1072.43 | 0.55 |
Y3267.43 | 0.37 | F343(H8) | 0.54 |
F343(H8) | 0.36 | N1884.46 | 0.54 |
F347(H8) | 0.35 | F135(EC1) | 0.53 |
R1653.50 | 0.35 | R2776.32 | 0.52 |
W2936.48 | 0.34 | F1563.41 | 0.50 |
W3187.35 | 0.34 | W133(EC1) | 0.50 |
Y911.55 | 0.34 | N861.50 | 0.49 |
Y3367.53 | 0.33 | I1443.29 | 0.48 |
F178(IC2) | 0.33 | Y961.60 | 0.48 |
E2295.35 | 0.33 | N1092.45 | 0.48 |
F135(EC1) | 0.33 | C1403.25 | 0.47 |
D1643.49 | 0.32 | N3327.49 | 0.46 |
I1443.29 | 0.31 | P134(EC1) | 0.46 |
T1603.45 | 0.29 | morphine | 0.45 |
Y2525.58 | 0.29 | Y2996.54 | 0.45 |
W2936.48 | 0.45 | ||
Y3267.43 | 0.45 | ||
Y3367.53 | 0.44 |
Residues completely exposed to the lipid bilayer are not included in the table. Common residues in the two systems are highlighted in bold.